Prevalence and Determinants of Migraine Among Headache Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUniversiti Tunku Abdul Rahman

About this trial

Migraine is a prevalent and disabling neurological condition that often coexists with other health issues, such as hypertension and impaired physical, mental, and social functioning. Understanding the prevalence of migraine and its associations with these health domains can provide valuable insights into the broader impact of migraine on overall well-being. By focusing on patients at the Affiliated Hospital of Hebei University of Engineering in China, this study can identify specific health burdens within this population, inform integrated clinical management strategies, and support the development of targeted interventions to improve patient outcomes and quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Patients with other major diseases or severe mental disorders;

History of endocrine, immune, or nervous system diseases or other severe somatic diseases.

Trial population

Patients attending at the Affiliated Hospital of Hebei University of Engineering, China.

Trial design

Design model

Ecologic or community

Time perspective

Cross-sectional

Treatments tested in this trial

  • Other intervention

    Participants are not assigned an intervention as part of the study.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Prevalence of migraine

The overall number and proportion of people with migraine (according to the International Classification of Headache Disorders, 3rd edition (ICHD-3))

Time frame
Day 1

Secondary outcomes

1

Correlation with hypertension

Hypertension will be assessed using self-reported hypertension status (Yes/ No)

Time frame
Day 1
2

Correlation with physical (physical function, pain intensity), mental (depression, anxiety, fatigue, sleep disturbance) and social (ability to participate in social roles and activities)

Patient-Reported Outcomes Measurement Information System (PROMIS) measures domains including physical (physical function, pain intensity), mental (depression, anxiety, fatigue, sleep disturbance) and social (ability to participate in social roles and activities). The total score of each domain is converted to a standardized T score. High scores mean more of the domains being measured.

Time frame
Day 1
3

Correlation with migraine disability

The MIDAS (Migraine Disability Assessment) is a validated questionnaire used to measure headache-related disability over the past three months. It consists of five questions, each addressing the number of days affected by migraines. Each answer is recorded as a number of days. The higher score indicating more severe migraine disability

Time frame
Day 1
4

Correlation with quality of life

The Migraine-Specific Quality of Life Questionnaire (MSQ) is a validated tool used to assess the impact of migraine on a patient's quality of life. Raw scores are first calculated by summing item responses for each domain. Raw scores are then transformed into a 0-100 scale, where higher scores indicate better quality of life.

Time frame
Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: